Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Mylan's Diclofenac Gel vs Voltaren in Knee Osteoarthritis
NCT03172780Phase 3Completed
- Sponsor
- Mylan
- Start
- May 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diclofenac in osteoarthritis (OA) (3 arms), sponsored by Mylan. Primary endpoints: Mean Change in the Total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score at 4 weeks and Change From Baseline in WOMAC Pain Subscale Score at 4 weeks. Started May 2017; status: completed.
02
Drugs
diclofenac
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03172780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03172780.